RIGEL PHARMACEUTICALS, INC., Issuer AND [TRUSTEE], TrusteeIndenture • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 20[·], among RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
·], AS WARRANT AGENTPreferred Stock Warrant Agreement • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
·], AS WARRANT AGENTCommon Stock Warrant Agreement • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
·], AS WARRANT AGENTWarrant Agreement • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
